A to Z

prozac

·October 4, 2016·4 min read

Newly Discovered Pathway in Brain Could Ease Depression

Researchers report they have discovered a new target for antidepressants which could help those for who other treatments for depression have failed.

Autism Featured Neuroscience Open Neuroscience Articles Psychology

·April 30, 2019·4 min read

Possible link between autism and antidepressants use during pregnancy: Mouse Study

A new study in mice reveals a possible link between the use of SSRI antidepressants during pregnancy and an increased risk of autism-like symptoms in offspring. Offspring exposed to fluoxetine (Prozac) in utero were more likely to exhibit impaired neurotransmission caused by an overactive serotonin receptor in the prefrontal cortex, an area of the brain implicated in modulating social behaviors. However, treating the mice with a compound that blocks the receptor alleviated the behavioral problems and improved working memory.

Featured Neuroscience Psychology

·August 23, 2021·5 min read

Prozac Changes Fat Composition of the Brain

Prozac reduced polyunsaturated fatty acid lipid concentrations in the brains of juvenile macaque monkeys.

Featured Neuroscience Psychology

·September 25, 2025·4 min read

Prozac May Rewire the Brain by Loosening Rigid Neural Circuits

A new study shows that fluoxetine, better known as Prozac, does more than increase serotonin—it changes how brain cells handle energy and rebuild connections. After two weeks of treatment, parvalbumin interneurons in the prefrontal cortex became less rigid, with mitochondrial energy genes reduced and plasticity genes upregulated.

Featured Neuroscience Visual Neuroscience

·October 21, 2021·4 min read

Prozac Pegged as Potential First Treatment for a Leading Cause of Blindness

Fluoxetine, the antidepressant commonly known as Prozac, may be beneficial for the treatment of age-related macular degeneration. Researchers found Prozac significantly slowed the rate at which people over 50 developed AMD.

Featured Neuroscience Psychology

·February 14, 2025·6 min read

Prozac Shows Promise in Fighting Infections & Sepsis

New research suggests that fluoxetine, commonly used as an antidepressant, may also help protect against infections and sepsis. Scientists found that the drug has antimicrobial properties and helps regulate the immune response, reducing the risk of tissue and organ damage.

Featured Neuroscience Psychology

·September 1, 2019·5 min read

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.

The image shows a schematic structure of Insulin-like growth factor-1.

Autism Featured

·January 31, 2013·4 min read

Researcher Uncovers Potential Cause, Biomarker for Autism and Proposes Study to Investigate Theory

Based on prior findings, researchers propose that depressed levels of insulin-like growth factor (IGF) in the blood of newborns could potentially serve as a biomarker for the later development of autism.

Featured Open Neuroscience Articles Psychology

·October 9, 2015·3 min read

Sex Reassignment Hormone Treatments Alter Brain Chemistry

A new study reports sex hormones taken by those undergoing gender reassignment can alter brain chemistry and increase risk for mood disorders, especially in men transitioning into women.

Featured Neuroscience Psychology

·July 7, 2025·5 min read

Timing of Prozac Treatment Shapes Lasting Mood, Brain Changes

New research reveals that the developmental timing of fluoxetine (Prozac) treatment profoundly influences long-term mood and brain function. In a rodent model, early postnatal treatment in males led to persistent anxiety and depression-like behaviors, while adolescent treatment reduced these behaviors.